In 2012 the European Cardiovascular Research Institute (ECRI) was founded as a European collaborative effort to perform Investigator Sponsored Studies in the field of cardiology.
STUDY DESIGN
The IVUS-CHIP trial is a randomized, controlled, multicenter, international, post-marketing study. A total of 2020 patients, in 7 European countries and approximately 40 hospitals, will be included, randomized in a 1:1 fashion to IVUS-guided PCI versus angio-guided PCI, and followed up for at least 2 years.
The IVUS-CHIP is an event-driven study; primary data analysis will take place after 169 patients have experienced an event.